Blog
RSS FeedPosted by Michael Wonder on 23 Mar 2020
Intra-Cellular prices schizophrenia drug at $1,320 per month
23 March 2020 - Intra-Cellular Therapies said on Monday its lead drug to treat schizophrenia was now available at U.S. ...
Posted by Michael Wonder on 23 Mar 2020
FDA and EMA collaborate to facilitate SARS-CoV-2 vaccine development
23 March 2020 - Vaccines offer a way to build immunity to a disease-causing microorganism before one has ever been exposed ...
Posted by Michael Wonder on 23 Mar 2020
Coronavirus (COVID-19) update: FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency
22 March 2020 - Today, as part of the U.S. FDA’s ongoing efforts to address the coronavirus pandemic (COVID-19), the agency ...
Posted by Michael Wonder on 23 Mar 2020
Scientists identify 69 drugs to test against the coronavirus
23 March 2020 - Two dozen of the medicines are already under investigation. Also on the list: chloroquine, a drug used ...
Posted by Michael Wonder on 23 Mar 2020
Insulin gains new pathway to increased competition
23 March 2020 - Today is a historic day and a landmark moment for patients with diabetes and other serious medical ...
Posted by Michael Wonder on 23 Mar 2020
Coronavirus patients in limbo as Gilead suspends emergency drug access
23 March 2020 - The company says it will switch to a broader approach for its experimental drug, remdesivir. But it ...
Posted by Michael Wonder on 23 Mar 2020
Fast-tracking research into treatments for COVID-19
21 March 2020 - The Australian Government will provide $13 million to fast-track research into treatments for the novel coronavirus (COVID-19). ...
Posted by Michael Wonder on 21 Mar 2020
Potential coronavirus treatment touted by Trump already in shortage, pharmacists say
19 March 2020 - An old malaria treatment that has been tried with some success against the new coronavirus and ...
Posted by Michael Wonder on 21 Mar 2020
Janssen announces Health Canada approval of Cabenuva, the first long-acting regimen for the treatment of HIV
20 March 2020 - Cabenuva offers adults living with HIV a new once-monthly injectable option for maintaining viral suppression. ...
Posted by Michael Wonder on 21 Mar 2020
U.S. pharma that makes potential coronavirus drug touted by Donald Trump doubled price to $19.88 a pill
20 March 2020 - Company calls hike in January during China outbreak coincidental and said it restored old price. ...
Posted by Michael Wonder on 21 Mar 2020
Teva to donate potential COVID-19 treatment, hydroxychloroquine sulphate tablets to US hospitals nationwide
20 March 2020 - Teva will donate 6 million tablets through wholesalers to hospitals by March 31, and more than ...
Posted by Michael Wonder on 21 Mar 2020
Generating comparative evidence on new drugs and devices after approval
21 March 2020 - Certain limitations of evidence available on drugs and devices at the time of market approval often persist ...
Posted by Michael Wonder on 20 Mar 2020
Generating comparative evidence on new drugs and devices before approval
21 March 2020 - Fewer than half of new drugs have data on their comparative benefits and harms against existing treatment ...
Posted by Michael Wonder on 20 Mar 2020
Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
20 March 2020 - Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of ...
Posted by Michael Wonder on 20 Mar 2020
US FDA issues complete response letter for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes
20 March 2020 - The U.S. FDA has issued a complete response letter for the supplemental new drug application of ...